Chr del(13q)
|
Multiple Myeloma
|
Chr del(13q)
|
Multiple Myeloma
|
bortezomib Resistant: C3 – Early Trials
|
bortezomib Resistant: C3 – Early Trials
|
Chr del(13q)
|
CLL
|
Chr del(13q)
|
CLL
|
BMF-219 Sensitive: D – Preclinical
|
BMF-219 Sensitive: D – Preclinical
|